These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16840174)

  • 41. Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway.
    Qin L; Ren Y; Chen AM; Guo FJ; Xu F; Gong C; Cheng P; Du Y; Liao H
    Mol Med Rep; 2014 Jul; 10(1):276-82. PubMed ID: 24787994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The transcription factor NF-ATc is essential for cardiac valve formation.
    Ranger AM; Grusby MJ; Hodge MR; Gravallese EM; de la Brousse FC; Hoey T; Mickanin C; Baldwin HS; Glimcher LH
    Nature; 1998 Mar; 392(6672):186-90. PubMed ID: 9515964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. VEGF and RANKL regulation of NFATc1 in heart valve development.
    Combs MD; Yutzey KE
    Circ Res; 2009 Sep; 105(6):565-74. PubMed ID: 19661463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosiglitazone inhibits endothelial proliferation and angiogenesis.
    Sheu WH; Ou HC; Chou FP; Lin TM; Yang CH
    Life Sci; 2006 Feb; 78(13):1520-8. PubMed ID: 16297938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lactate stimulates endothelial cell migration.
    Beckert S; Farrahi F; Aslam RS; Scheuenstuhl H; Königsrainer A; Hussain MZ; Hunt TK
    Wound Repair Regen; 2006; 14(3):321-4. PubMed ID: 16808811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sculpting heart valves with NFATc and VEGF.
    Lambrechts D; Carmeliet P
    Cell; 2004 Sep; 118(5):532-4. PubMed ID: 15339657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocardial-to-mesenchymal transformation and mesenchymal cell colonization at the onset of human cardiac valve development.
    Monaghan MG; Linneweh M; Liebscher S; Van Handel B; Layland SL; Schenke-Layland K
    Development; 2016 Feb; 143(3):473-82. PubMed ID: 26674310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A method for the isolation of glomerular and tubulointerstitial endothelial cells and a comparison of characteristics with the human umbilical vein endothelial cell model.
    McGinn S; Poronnik P; Gallery ED; Pollock CA
    Nephrology (Carlton); 2004 Aug; 9(4):229-37. PubMed ID: 15363055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effects of pioglitazone on vascular endothelial cell dysfunction induced by high glucose via inhibition of IKKα/β-NFκB signaling mediated by PPARγ in vitro.
    Chen C; Peng S; Chen F; Liu L; Li Z; Zeng G; Huang Q
    Can J Physiol Pharmacol; 2017 Dec; 95(12):1480-1487. PubMed ID: 28787583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.
    Marafioti T; Pozzobon M; Hansmann ML; Ventura R; Pileri SA; Roberton H; Gesk S; Gaulard P; Barth TF; Du MQ; Leoncini L; Möller P; Natkunam Y; Siebert R; Mason DY
    Br J Haematol; 2005 Feb; 128(3):333-42. PubMed ID: 15667535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma.
    Tsukahara T; Tsukahara R; Haniu H; Matsuda Y; Murakami-Murofushi K
    Mol Cell Endocrinol; 2015 Sep; 412():320-9. PubMed ID: 26007326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2.
    Paruchuri S; Yang JH; Aikawa E; Melero-Martin JM; Khan ZA; Loukogeorgakis S; Schoen FJ; Bischoff J
    Circ Res; 2006 Oct; 99(8):861-9. PubMed ID: 16973908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Contribution of EDF1 to PPARγ Transcriptional Activation in VEGF-Treated Human Endothelial Cells.
    Cazzaniga A; Locatelli L; Castiglioni S; Maier J
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29933613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rosiglitazone inhibits HMC-1 cell migration and adhesion through a peroxisome proliferator-activated receptor gamma-dependent mechanism.
    Zhang G; Yang J; Li P; Cao J; Nie H
    Iran J Allergy Asthma Immunol; 2014 Feb; 13(1):11-8. PubMed ID: 24338223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nfatc1 Promotes Interstitial Cell Formation During Cardiac Valve Development in Zebrafish.
    Gunawan F; Gentile A; Gauvrit S; Stainier DYR; Bensimon-Brito A
    Circ Res; 2020 Apr; 126(8):968-984. PubMed ID: 32070236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated vascular endothelial cell growth factor affects mesocardial morphogenesis and inhibits normal heart bending.
    Drake CJ; Wessels A; Trusk T; Little CD
    Dev Dyn; 2006 Jan; 235(1):10-8. PubMed ID: 16170779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peroxisome proliferator‑activated receptor γ mediates porcine placental angiogenesis through hypoxia inducible factor‑, vascular endothelial growth factor‑ and angiopoietin‑mediated signaling.
    Zhang J; Peng X; Yuan A; Xie Y; Yang Q; Xue L
    Mol Med Rep; 2017 Sep; 16(3):2636-2644. PubMed ID: 28677792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    Kang BY; Park K; Kleinhenz JM; Murphy TC; Sutliff RL; Archer D; Hart CM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):131-144. PubMed ID: 27612006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish.
    Lee YM; Cope JJ; Ackermann GE; Goishi K; Armstrong EJ; Paw BH; Bischoff J
    Dev Dyn; 2006 Jan; 235(1):29-37. PubMed ID: 16170785
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development.
    Garnier V; Traboulsi W; Salomon A; Brouillet S; Fournier T; Winkler C; Desvergne B; Hoffmann P; Zhou QY; Congiu C; Onnis V; Benharouga M; Feige JJ; Alfaidy N
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E357-69. PubMed ID: 26081281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.